In this context, the use of transferrin (Tf) as a ligand model for the capture of CTCs has been widely studied since it is known that the concentration of the Tf receptor in many tumor phenotypic cells is considerably higher than in healthy cells [23,24,25,26,27]. This evidence concerns the gene TF and neoplasm.